Microbial siderophore-based iron assimilation and therapeutic applications

BioMetals

Volumn 29, Issue 3, 2016, Pages 377-388

  Li, Kunhua ^a   Chen, Wei Hung ^a   Bruner, Steven D ^a  

^a University of Florida   (United States)

Author keywords

Biosynthetic pathways; Iron assimilation; Siderophore; Therapeutic application

Indexed keywords

IRON; SIDEROPHORE;

BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BINDING AFFINITY; BIOSYNTHESIS; GENE CLUSTER; METAL BINDING; NONHUMAN; REVIEW; ANIMAL; BACTERIUM; CHEMISTRY; HUMAN; METABOLISM;

ANIMALS; BACTERIA; HUMANS; IRON; SIDEROPHORES;

EID: 84965014151     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-016-9935-3     Document Type: Review

References (102)

1. Barry SM, Challis GL (2009) Recent advances in siderophore biosynthesis. Curr Opin Chem Biol 13:205–215. doi:10.1016/j.cbpa.2009.03.008
2. Bleuel C, Große C, Taudte N et al (2005) TolC Is Involved in enterobactin efflux across the outer membrane of Escherichia coli. J Bacteriol 187:6701–6707. doi:10.1128/JB.187.19.6701
3. Braun V (2001) Iron uptake mechanisms and their regulation in pathogenic bacteria. Int J Med Microbiol 291:67–79. doi:10.1078/1438-4221-00103
4. Braun V, Hantke K, Winkelmann G, Carrano CJ (1997) Transition metals in microbial metabolism. Harwood, Amsterdam
5. Brown MF, Mitton-Fry MJ, Arcari JT et al (2013) Pyridone-conjugated monobactam antibiotics with Gram-negative activity. J Med Chem 56:5541–5552. doi:10.1021/jm400560z
6. Butler MS, Blaskovich MA, Cooper MA (2013) Antibiotics in the clinical pipeline in 2013. J Antibiot 66:571–591. doi:10.1038/ja.2013.86
7. Caza M, Lépine F, Milot S, Dozois CM (2008) Specific roles of the iroBCDEN genes in virulence of an avian pathogenic Escherichia coli O78 strain and in production of salmochelins. Infect Immun 76:3539–3549. doi:10.1128/IAI.00455-08
8. Caza M, Lépine F, Dozois CM (2011) Secretion, but not overall synthesis, of catecholate siderophores contributes to virulence of extraintestinal pathogenic Escherichia coli. Mol Microbiol 80:266–282. doi:10.1111/j.1365-2958.2011.07570.x
9. Chairatana P, Zheng T, Nolan EM (2015) Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of b-lactams for pathogen-selective killing of Escherichia coli. Chem Sci 6:4458–4471. doi:10.1039/C5SC00962F
10. Chu BCH, Vogel HJ (2011) A structural and functional analysis of type III periplasmic and substrate binding proteins: their role in bacterial siderophore and heme transport. Biol Chem 392:39–52. doi:10.1515/BC.2011.012
11. Chu BCH, Otten R, Krewulak KD et al (2014) The solution structure, binding properties, and dynamics of the bacterial siderophore-binding protein FepB. J Biol Chem 289:29219–29234. doi:10.1074/jbc.M114.564021
12. Condurso HL, Bruner SD (2012) Structure and noncanonical chemistry of nonribosomal peptide biosynthetic machinery. Nat Prod Rep 29:1099–1110. doi:10.1039/c2np20023f
13. Crouch M-LV, Castor M, Karlinsey JE et al (2008) Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. Mol Microbiol 67:971–983. doi:10.1111/j.1365-2958.2007.06089.x
14. de Carvalho CCCR, Fernandes P (2014) Siderophores as “Trojan Horses”: tackling multidrug resistance? Front Microbiol 5:1–3. doi:10.3389/fmicb.2014.00290
15. Deneer HG, Healey V, Boychuk I (1995) Reduction of exogenous ferric iron by a surface-associated ferric reductase of Listeria spp. Microbiology 141:1985–1992. doi:10.1099/13500872-141-8-1985
16. Du D, Wang Z, James NR et al (2014) Structure of the AcrAB-TolC multidrug efflux pump. Nature 509:512–515. doi:10.1038/nature13205
17. Ferguson AD, Chakraborty R, Smith BS et al (2002) Structural basis of gating by the outer membrane transporter FecA. Science 295:1715–1719. doi:10.1126/science.1067313
18. Ferreras JA, Ryu J-S, Di Lello F et al (2005) Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis. Nat Chem Biol 1:29–32. doi:10.1038/nchembio706
19. Fischbach MA, Lin H, Liu DR, Walsh CT (2005) In vitro characterization of IroB, a pathogen-associated C-glycosyltransferase. Proc Natl Acad Sci USA 102:571–576. doi:10.1073/pnas.0408463102
20. Flanagan ME, Brickner SJ, Lall M et al (2011) Preparation, Gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diols. ACS Med Chem Lett 2:385–390. doi:10.1021/ml200012f
21. Fukushima T, Allred BE, Sia AK et al (2013) Gram-positive siderophore-shuttle with iron-exchange from Fe-siderophore to apo-siderophore by Bacillus cereus YxeB. Proc Natl Acad Sci 110:13821–13826. doi:10.1073/pnas.1304235110
22. Fukushima T, Allred BE, Raymond KN (2014) Direct evidence of iron uptake by the Gram-positive siderophore-shuttle mechanism without iron reduction. ACS Chem Biol 9:2092–2100. doi:10.1021/cb500319n
23. Furrer JL, Sanders DN, Hook-Barnard IG, McIntosh MA (2002) Export of the siderophore enterobactin in Escherichia coli: involvement of a 43 kDa membrane exporter. Mol Microbiol 44:1225–1234. doi:10.1046/j.1365-2958.2002.02885.x
24. Gauglitz JM, Iinishi A, Ito Y, Butler A (2014) Microbial tailoring of acyl peptidic siderophores. Biochemistry 53:2624–2631. doi:10.1021/bi500266x
25. Giessen TW, Franke KB, Knappe TA et al (2012) Isolation, structure elucidation, and biosynthesis of an unusual hydroxamic acid ester-containing siderophore from Actinosynnema mirum. J Nat Prod 75:905–914. doi:10.1021/np300046k
26. Górska A, Sloderbach A, Marszałł MP (2014) Siderophore-drug complexes: potential medicinal applications of the “Trojan horse” strategy. Trends Pharmacol Sci 35:442–449. doi:10.1016/j.tips.2014.06.007
27. Granger JB, Lu Z, Ferguson JB et al (2013) Cloning, expression, purification and characterization of an iron-dependent regulator protein from Thermobifida fusca. Protein Expr Purif 92:190–194. doi:10.1016/j.pep.2013.09.010
28. Gründlinger M, Yasmin S, Lechner BE et al (2013) Fungal siderophore biosynthesis is partially localized in peroxisomes. Mol Microbiol 88:862–875. doi:10.1111/mmi.12225
29. Han S, Zaniewski RP, Marr ES et al (2010) Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 107:22002–22007. doi:10.1073/pnas.1013092107
30. Hider RC, Kong X (2010) Chemistry and biology of siderophores. Nat Prod Rep 27:637–657. doi:10.1039/b906679a
31. Higgins PG, Stefanik D, Page MGP et al (2012) In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii. J Antimicrob Chemother 67:1167–1169. doi:10.1093/jac/dks009
32. Hofer B, Dantier C, Gebhardt K et al (2013) Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli. J Antimicrob Chemother 68:1120–1129. doi:10.1093/jac/dks527
33. Horiyama T, Nishino K (2014) AcrB, AcrD, and MdtABC Multidrug Efflux Systems Are Involved in Enterobactin Export in Escherichia coli. PLoS One 9:e108642. doi:10.1371/journal.pone.0108642
34. Ji C, Miller PA, Miller MJ (2012) Iron transport-mediated drug delivery: practical syntheses and in vitro antibacterial studies of tris-catecholate siderophore-aminopenicillin conjugates reveals selectively potent antipseudomonal activity. J Am Chem Soc 134:9898–9901. doi:10.1021/ja303446w
35. Johnstone T, Nolan E (2015) Beyond iron: non-classical functions of bacterial siderophores. Dalt Trans 44:6320–6339. doi:10.1039/C4DT03559C
36. Jones CM, Wells RM, Madduri AVR et al (2014) Self-poisoning of Mycobacterium tuberculosis by interrupting siderophore recycling. Proc Natl Acad Sci USA 111:1945–1950. doi:10.1073/pnas.1311402111
37. Jordan LD, Zhou Y, Smallwood CR et al (2013) Energy-dependent motion of TonB in the Gram-negative bacterial inner membrane. Proc Natl Acad Sci USA 110:11553–11558. doi:10.1073/pnas.1304243110
38. Juárez-Hernández RE, Franzblau SG, Miller MJ (2012) Syntheses of mycobactin analogs as potent and selective inhibitors of Mycobacterium tuberculosis. Org Biomol Chem 10:7584. doi:10.1039/c2ob26077h
39. Kem MP, Butler A (2015) Acyl peptidic siderophores: structures, biosyntheses and post-assembly modifications. Biometals 28:445–459. doi:10.1007/s10534-015-9827-y
40. Kem MP, Naka H, Iinishi A et al (2015) Fatty acid hydrolysis of acyl marinobactin siderophores by marinobacter acylases. Biochemistry 54:744–752. doi:10.1021/bi5013673
41. Kishimoto S, Nishimura S, Kakeya H (2015) Total synthesis and structure revision of mirubactin, and its iron binding activity. Chem Lett 44:1303–1305. doi:10.1246/cl.150520
42. Kline T, Fromhold M, McKennon T et al (2000) Antimicrobial effects of novel siderophores linked to b-lactam antibiotics. Bioorg Med Chem 8:73–93. doi:10.1016/S0968-0896(99)00261-8
43. Krewulak KD, Vogel HJ (2011) TonB or not TonB: is that the question? Biochem Cell Biol 89:87–97. doi:10.1139/O10-141
44. Larsen NA, Lin H, Wei R et al (2006) Structural characterization of enterobactin hydrolase IroE. Biochemistry 45:10184–10190. doi:10.1021/bi060950i
45. Lazos O, Tosin M, Slusarczyk AL et al (2010) Biosynthesis of the putative siderophore erythrochelin requires unprecedented crosstalk between separate nonribosomal peptide gene clusters. Chem Biol 17:160–173. doi:10.1016/j.chembiol.2010.01.011
46. Li K, Bruner SD (2016) Structure and functional analysis of the siderophore periplasmic binding protein from the fuscachelin gene cluster of Thermobifida fusca. Proteins 84:118–128. doi:10.1002/prot.24959
47. Li XZ, Nikaido H, Poole K (1995) Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother 39:1948–1953. doi:10.1128/AAC.39.9.1948
48. Li K, Chen W-H, Bruner SD (2015) Structure and mechanism of the siderophore-interacting protein from the fuscachelin gene cluster of Thermobifida fusca. Biochemistry 54:3989–4000. doi:10.1021/acs.biochem.5b00354
49. Lin H, Fischbach MA, Liu DR, Walsh CT (2005) In vitro characterization of salmochelin and enterobactin trilactone hydrolases IroD, IroE, and Fes. J Am Chem Soc 127:11075–11084. doi:10.1021/ja0522027
50. Liu Z, Reba S, Chen W-D et al (2014) Regulation of mammalian siderophore 2,5-DHBA in the innate immune response to infection. J Exp Med 211:1197–1213. doi:10.1084/jem.20132629
51. Lun S, Guo H, Adamson J et al (2013) Pharmacokinetic and in vivo efficacy studies of the mycobactin biosynthesis inhibitor salicyl-AMS in mice. Antimicrob Agents Chemother 57:5138–5140. doi:10.1128/AAC.00918-13
52. Mathavan I, Zirah S, Mehmood S et al (2014) Structural basis for hijacking siderophore receptors by antimicrobial lasso peptides. Nat Chem Biol 10:340–342. doi:10.1038/nchembio.1499
53. Matzanke BF, Anemüller S, Schünemann V et al (2004) FhuF, part of a siderophore-reductase system. Biochemistry 43:1386–1392. doi:10.1021/bi0357661
54. McPherson CJ, Aschenbrenner LM, Lacey BM et al (2012) Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam. Antimicrob Agents Chemother 56:6334–6342. doi:10.1128/AAC.01345-12
55. Miethke M, Marahiel MA (2007) Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev 71:413–451. doi:10.1128/MMBR.00012-07
56. Miethke M, Bisseret P, Beckering CL et al (2006) Inhibition of aryl acid adenylation domains involved in bacterial siderophore synthesis. FEBS J 273:409–419. doi:10.1111/j.1742-4658.2005.05077.x
57. Miethke M, Schmidt S, Marahiel MA (2008) The major facilitator superfamily-type transporter YmfE and the multidrug-efflux activator Mta mediate bacillibactin secretion in Bacillus subtilis. J Bacteriol 190:5143–5152. doi:10.1128/JB.00464-08
58. Miethke M, Hou J, Marahiel MA (2011a) The siderophore-interacting protein YqjH acts as a ferric reductase in different iron assimilation pathways of Escherichia coli. Biochemistry 50:10951–10964. doi:10.1021/bi201517h
59. Miethke M, Pierik AJ, Peuckert F et al (2011b) Identification and characterization of a novel-type ferric siderophore reductase from a Gram-positive extremophile. J Biol Chem 286:2245–2260. doi:10.1074/jbc.M110.192468
60. Milano A, Pasca MR, Provvedi R et al (2009) Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5–MmpL5 efflux system. Tuberculosis 89:84–90. doi:10.1016/j.tube.2008.08.003
61. Miller MJ, Walz AJ, Zhu H et al (2011) Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malaria. J Am Chem Soc 133:2076–2079. doi:10.1021/ja109665t
62. Murphy-Benenato KE, Bhagunde PR, Chen A et al (2015a) Discovery of efficacious Pseudomonas aeruginosa-targeted siderophore-conjugated monocarbams by application of a semi-mechanistic pharmacokinetic/pharmacodynamic model. J Med Chem 58:2195–2205. doi:10.1021/jm501506f
63. Murphy-Benenato KE, Dangel B, Davis HE et al (2015b) SAR and structural analysis of siderophore-conjugated monocarbam inhibitors of Pseudomonas aeruginosa PBP3. ACS Med Chem Lett 6:537–542. doi:10.1021/acsmedchemlett.5b00026
64. Naikare H, Butcher J, Flint A et al (2013) Campylobacter jejuni ferric–enterobactin receptor CfrA is TonB3 dependent and mediates iron acquisition from structurally different catechol siderophores. Metallomics 5:988. doi:10.1039/c3mt20254b
65. Nikaido H, Pagès JM (2012) Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev 36:340–363. doi:10.1111/j.1574-6976.2011.00290.x
66. Olivieri NF, Brittenham GM, Matsui D et al (1995) Iron-chelation therapy with oral deferiprone in patients with thalassemia major. N Engl J Med 332:918–922. doi:10.1056/NEJM199504063321404
67. Ollis AA, Postle K (2012a) Identification of functionally important TonB-ExbD periplasmic domain interactions in vivo. J Bacteriol 194:3078–3087. doi:10.1128/JB.00018-12
68. Ollis AA, Postle K (2012b) ExbD mutants define initial stages in TonB energization. J Mol Biol 415:237–247. doi:10.1016/j.jmb.2011.11.005
69. Page MGP, Dantier C, Desarbre E (2010) In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant Gram-negative bacilli. Antimicrob Agents Chemother 54:2291–2302. doi:10.1128/AAC.01525-09
70. Pan SJ, Link AJ (2011) Sequence diversity in the lasso peptide framework: discovery of functional microcin J25 variants with multiple amino acid substitutions. J Am Chem Soc 133:5016–5023. doi:10.1021/ja1109634
71. Pawelek PD, Croteau N, Ng-Thow-Hing C et al (2006) Structure of TonB in complex with FhuA. E. coli outer membrane receptor. Science 312:1399–1402. doi:10.1126/science.1128057
72. Pei X-Y, Hinchliffe P, Symmons MF et al (2011) Structures of sequential open states in a symmetrical opening transition of the TolC exit duct. Proc Natl Acad Sci USA 108:2112–2117. doi:10.1073/pnas.1012588108
73. Penwell WF, DeGrace N, Tentarelli S et al (2015) Discovery and characterization of new hydroxamate siderophores, baumannoferrin A and B, produced by Acinetobacter baumannii. ChemBioChem 16:1896–1904. doi:10.1002/cbic.201500147
74. Pramanik A, Stroeher UH, Krejci J et al (2007) Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae. Int J Med Microbiol 297:459–469. doi:10.1016/j.ijmm.2007.03.002
75. Radhakrishnan A, Kumar N, Wright CC et al (2014) Crystal structure of the transcriptional regulator Rv0678 of Mycobacterium tuberculosis. J Biol Chem 289:16526–16540. doi:10.1074/jbc.M113.538959
76. Raymond-Bouchard I, Carroll CS, Nesbitt JR et al (2012) Structural requirements for the activity of the MirB ferrisiderophore transporter of Aspergillus fumigatus. Eukaryot Cell 11:1333–1344. doi:10.1128/EC.00159-12
77. Reddy VS, Shlykov MA, Castillo R et al (2012) The major facilitator superfamily (MFS) revisited. FEBS J 279:2022–2035. doi:10.1111/j.1742-4658.2012.08588.x
78. Rees DC, Johnson E, Lewinson O (2009) ABC transporters: the power to change. Nat Rev Mol Cell Biol 10:218–227. doi:10.1038/nrm2646
79. Rodriguez GM, Smith I (2006) Identification of an ABC transporter required for iron acquisition and virulence in Mycobacterium tuberculosis. J Bacteriol 188:424–430. doi:10.1128/JB.188.2.424
80. Ryndak MB, Wang S, Smith I, Rodriguez GM (2010) The Mycobacterium tuberculosis high-affinity iron importer, IrtA, contains an FAD-binding domain. J Bacteriol 192:861–869. doi:10.1128/JB.00223-09
81. Saha R, Saha N, Donofrio RS, Bestervelt LL (2012) Microbial siderophores: a mini review. J Microbiol 52:1–15. doi:10.1002/jobm.201100552
82. Soe CZ, Codd R (2014) Unsaturated macrocyclic dihydroxamic acid siderophores produced by Shewanella putrefaciens using precursor-directed biosynthesis. ACS Chem Biol 9:945–956. doi:10.1021/cb400901j
83. Starr J, Brown MF, Aschenbrenner L et al (2014) Siderophore receptor-mediated uptake of lactivicin analogues in Gram-negative bacteria. J Med Chem 57:3845–3855. doi:10.1021/jm500219c
84. Sulochana MB, Jayachandra SY, Kumar SKA, Dayanand A (2014) Antifungal attributes of siderophore produced by the Pseudomonas aeruginosa JAS-25. J Basic Microbiol 54:418–424. doi:10.1002/jobm.201200770
85. Sutak R, Lesuisse E, Tachezy J, Richardson DR (2008) Crusade for iron: iron uptake in unicellular eukaryotes and its significance for virulence. Trends Microbiol 16:261–268. doi:10.1016/j.tim.2008.03.005
86. Sverzhinsky A, Fabre L, Cottreau AL et al (2014) Coordinated rearrangements between cytoplasmic and periplasmic domains of the membrane protein complex ExbB-ExbD of Escherichia coli. Structure 22:791–797. doi:10.1016/j.str.2014.02.010
87. Tong Y, Guo M (2009) Bacterial heme-transport proteins and their heme-coordination modes. Arch Biochem Biophys 481:1–15. doi:10.1016/j.abb.2008.10.013
88. Vega DE, Young KD (2013) Accumulation of periplasmic enterobactin impairs the growth and morphology of Escherichia coli tolC mutants. Mol Microbiol 91:508–521. doi:10.1111/mmi.12473
89. Wang S, Wu Y, Outten FW (2011) Fur and the novel regulator YqjI control transcription of the ferric reductase gene yqjH in Escherichia coli. J Bacteriol 193:563–574. doi:10.1128/JB.01062-10
90. Wang S, Blahut M, Wu Y et al (2014) Communication between binding sites is required for Yqji regulation of target promoters within the yqjH-yqjI intergenic region. J Bacteriol 196:3199–3207. doi:10.1128/JB.01835-14
91. Weinberg ED (2009) Iron availability and infection. Biochim Biophys Acta Gen Subj 1790:600–605. doi:10.1016/j.bbagen.2008.07.002
92. Wells RM, Jones CM, Xi Z et al (2013) Discovery of a siderophore export system essential for virulence of Mycobacterium tuberculosis. PLoS Pathog 1:e1003120. doi:10.1371/journal.ppat.1003120
93. Wencewicz TA, Miller MJ (2013) Biscatecholate–monohydroxamate mixed ligand siderophore–carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii. J Med Chem 56:4044–4052. doi:10.1021/jm400265k
94. Wencewicz TA, Möllmann U, Long TE, Miller MJ (2009) Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin “Trojan Horse” antibiotics and synthetic desferridanoxamine-antibiotic conjugates. Biometals 22:633–648. doi:10.1007/s10534-009-9218-3
95. Wencewicz TA, Long TE, Möllmann U, Miller MJ (2013) Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus. Bioconjug Chem 24:473–486. doi:10.1021/bc300610f
96. Woo J-S, Zeltina A, Goetz BA, Locher KP (2012) X-ray structure of the Yersinia pestis heme transporter HmuUV. Nat Struct Mol Biol 19:1310–1315. doi:10.1038/nsmb.2417
97. Wurst JM, Drake EJ, Theriault JR et al (2014) Identification of inhibitors of PvdQ, an enzyme involved in the synthesis of the siderophore pyoverdine. ACS Chem Biol 9:1536–1544. doi:10.1021/cb5001586
98. Yan N (2015) Structural biology of the major facilitator superfamily transporters. Annu Rev Biophys 44:257–283. doi:10.1146/annurev-biophys-060414-033901
99. Zane HK, Naka H, Rosconi F et al (2014) Biosynthesis of amphi-enterobactin siderophores by Vibrio harveyi BAA-1116: identification of a bifunctional nonribosomal peptide synthetase condensation domain. J Am Chem Soc 136:5615–5618. doi:10.1021/ja5019942
100. Zeng X, Mo Y, Xu F, Lin J (2013) Identification and characterization of a periplasmic trilactone esterase, Cee, revealed unique features of ferric enterobactin acquisition in Campylobacter. Mol Microbiol 87:594–608. doi:10.1111/mmi.12118
101. Zheng T, Nolan EM (2014) Enterobactin-mediated delivery of b-lactam antibiotics enhances antibacterial activity against pathogenic Escherichia coli. J Am Chem Soc 136:9677–9691. doi:10.1021/ja503911p
102. Zheng T, Bullock JL, Nolan EM (2012) Siderophore-mediated cargo delivery to the cytoplasm of Escherichia coli and Pseudomonas aeruginosa: syntheses of monofunctionalized enterobactin scaffolds and evaluation of enterobactin-cargo conjugate uptake. J Am Chem Soc 134:18388–18400. doi:10.1021/ja3077268